Jump Financial LLC Decreases Stock Position in Progyny, Inc. (NASDAQ:PGNY)

Jump Financial LLC lowered its holdings in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 61.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 97,932 shares of the company's stock after selling 156,168 shares during the quarter. Jump Financial LLC owned 0.12% of Progyny worth $1,689,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in PGNY. Signaturefd LLC lifted its position in Progyny by 1,355.0% in the fourth quarter. Signaturefd LLC now owns 1,455 shares of the company's stock worth $25,000 after buying an additional 1,355 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Progyny by 341.4% in the 4th quarter. GAMMA Investing LLC now owns 1,611 shares of the company's stock worth $28,000 after acquiring an additional 1,246 shares during the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Progyny by 108.4% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company's stock worth $51,000 after acquiring an additional 1,526 shares during the last quarter. Caitlin John LLC grew its holdings in Progyny by 2,974.8% during the 4th quarter. Caitlin John LLC now owns 3,290 shares of the company's stock valued at $57,000 after purchasing an additional 3,183 shares during the last quarter. Finally, SBI Securities Co. Ltd. purchased a new stake in Progyny in the 4th quarter worth about $74,000. 94.93% of the stock is owned by hedge funds and other institutional investors.

Progyny Stock Down 1.4 %

PGNY stock traded down $0.32 during trading on Friday, hitting $22.58. 149,178 shares of the company's stock traded hands, compared to its average volume of 1,737,406. The business has a fifty day simple moving average of $21.94 and a two-hundred day simple moving average of $19.01. The firm has a market capitalization of $1.93 billion, a P/E ratio of 38.95, a PEG ratio of 2.39 and a beta of 1.33. Progyny, Inc. has a 1 year low of $13.39 and a 1 year high of $33.84.

Analysts Set New Price Targets

Several brokerages have issued reports on PGNY. JPMorgan Chase & Co. boosted their target price on Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a research report on Tuesday, January 28th. Bank of America boosted their price objective on Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a report on Tuesday, February 11th. Canaccord Genuity Group increased their target price on Progyny from $17.00 to $23.00 and gave the stock a "hold" rating in a research note on Friday, February 28th. Finally, BTIG Research raised shares of Progyny from a "neutral" rating to a "buy" rating and set a $28.00 target price for the company in a research note on Monday, March 31st. Eight analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $23.64.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.